Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents

Bacteria of the genus <i>Staphylococcus</i> are significant challenge for medicine, as many species are resistant to multiple antibiotics and some are even to all of the antibiotics we use. One of the approaches to developing new therapeutics to treat staphylococcal infections is the use...

Full description

Bibliographic Details
Main Authors: Natalia N. Golosova, Andrey L. Matveev, Nina V. Tikunova, Yana A. Khlusevich, Yulia N. Kozlova, Vera V. Morozova, Igor V. Babkin, Tatiana A. Ushakova, Elena V. Zhirakovskaya, Elizaveta A. Panina, Elena I. Ryabchikova, Artem Y. Tikunov
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/3/385
_version_ 1797239110253936640
author Natalia N. Golosova
Andrey L. Matveev
Nina V. Tikunova
Yana A. Khlusevich
Yulia N. Kozlova
Vera V. Morozova
Igor V. Babkin
Tatiana A. Ushakova
Elena V. Zhirakovskaya
Elizaveta A. Panina
Elena I. Ryabchikova
Artem Y. Tikunov
author_facet Natalia N. Golosova
Andrey L. Matveev
Nina V. Tikunova
Yana A. Khlusevich
Yulia N. Kozlova
Vera V. Morozova
Igor V. Babkin
Tatiana A. Ushakova
Elena V. Zhirakovskaya
Elizaveta A. Panina
Elena I. Ryabchikova
Artem Y. Tikunov
author_sort Natalia N. Golosova
collection DOAJ
description Bacteria of the genus <i>Staphylococcus</i> are significant challenge for medicine, as many species are resistant to multiple antibiotics and some are even to all of the antibiotics we use. One of the approaches to developing new therapeutics to treat staphylococcal infections is the use of bacteriophages specific to these bacteria or the lytic enzymes of such bacteriophages, which are capable of hydrolyzing the cell walls of these bacteria. In this study, a new bacteriophage vB_SepP_134 (St 134) specific to <i>Staphylococcus epidermidis</i> was described. This podophage, with a genome of 18,275 bp, belongs to the <i>Andhravirus</i> genus. St 134 was able to infect various strains of 12 of the 21 tested coagulase-negative <i>Staphylococcus</i> species and one clinical strain from the <i>Staphylococcus aureus</i> complex. The genes encoding endolysin (LysSte134_1) and tail tip lysin (LysSte134_2) were identified in the St 134 genome. Both enzymes were cloned and produced in <i>Escherichia coli</i> cells. The endolysin LysSte134_1 demonstrated catalytic activity against peptidoglycans isolated from <i>S. aureus, S. epidermidis</i>, <i>Staphylococcus haemolyticus</i>, and <i>Staphylococcus warneri</i>. LysSte134_1 was active against <i>S. aureus</i> and <i>S. epidermidis</i> planktonic cells and destroyed the biofilms formed by clinical strains of <i>S. aureus</i> and <i>S. epidermidis</i>.
first_indexed 2024-04-24T17:46:19Z
format Article
id doaj.art-938888f3f07c442793effbf137af1d76
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-04-24T17:46:19Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-938888f3f07c442793effbf137af1d762024-03-27T14:07:44ZengMDPI AGViruses1999-49152024-02-0116338510.3390/v16030385Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological AgentsNatalia N. Golosova0Andrey L. Matveev1Nina V. Tikunova2Yana A. Khlusevich3Yulia N. Kozlova4Vera V. Morozova5Igor V. Babkin6Tatiana A. Ushakova7Elena V. Zhirakovskaya8Elizaveta A. Panina9Elena I. Ryabchikova10Artem Y. Tikunov11Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, RussiaBacteria of the genus <i>Staphylococcus</i> are significant challenge for medicine, as many species are resistant to multiple antibiotics and some are even to all of the antibiotics we use. One of the approaches to developing new therapeutics to treat staphylococcal infections is the use of bacteriophages specific to these bacteria or the lytic enzymes of such bacteriophages, which are capable of hydrolyzing the cell walls of these bacteria. In this study, a new bacteriophage vB_SepP_134 (St 134) specific to <i>Staphylococcus epidermidis</i> was described. This podophage, with a genome of 18,275 bp, belongs to the <i>Andhravirus</i> genus. St 134 was able to infect various strains of 12 of the 21 tested coagulase-negative <i>Staphylococcus</i> species and one clinical strain from the <i>Staphylococcus aureus</i> complex. The genes encoding endolysin (LysSte134_1) and tail tip lysin (LysSte134_2) were identified in the St 134 genome. Both enzymes were cloned and produced in <i>Escherichia coli</i> cells. The endolysin LysSte134_1 demonstrated catalytic activity against peptidoglycans isolated from <i>S. aureus, S. epidermidis</i>, <i>Staphylococcus haemolyticus</i>, and <i>Staphylococcus warneri</i>. LysSte134_1 was active against <i>S. aureus</i> and <i>S. epidermidis</i> planktonic cells and destroyed the biofilms formed by clinical strains of <i>S. aureus</i> and <i>S. epidermidis</i>.https://www.mdpi.com/1999-4915/16/3/385bacteriophageendolysin<i>Staphylococcus epidermidis</i><i>Staphylococcus aureus</i>antimicrobial agentbiofilm
spellingShingle Natalia N. Golosova
Andrey L. Matveev
Nina V. Tikunova
Yana A. Khlusevich
Yulia N. Kozlova
Vera V. Morozova
Igor V. Babkin
Tatiana A. Ushakova
Elena V. Zhirakovskaya
Elizaveta A. Panina
Elena I. Ryabchikova
Artem Y. Tikunov
Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
Viruses
bacteriophage
endolysin
<i>Staphylococcus epidermidis</i>
<i>Staphylococcus aureus</i>
antimicrobial agent
biofilm
title Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
title_full Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
title_fullStr Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
title_full_unstemmed Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
title_short Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents
title_sort bacteriophage vb sepp 134 and endolysin lysste 134 1 as potential staphylococcus biofilm removing biological agents
topic bacteriophage
endolysin
<i>Staphylococcus epidermidis</i>
<i>Staphylococcus aureus</i>
antimicrobial agent
biofilm
url https://www.mdpi.com/1999-4915/16/3/385
work_keys_str_mv AT nataliangolosova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT andreylmatveev bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT ninavtikunova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT yanaakhlusevich bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT yuliankozlova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT veravmorozova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT igorvbabkin bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT tatianaaushakova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT elenavzhirakovskaya bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT elizavetaapanina bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT elenairyabchikova bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents
AT artemytikunov bacteriophagevbsepp134andendolysinlysste1341aspotentialstaphylococcusbiofilmremovingbiologicalagents